FDA Issues Draft Guidance on Its New Platform Technology Designation Program

Retrieved on: 2024-06-12 17:22:48

Tags for this article:

Food and Drug Administration

Biotechnology products

Center for Biologics Evaluation and Research

Biologics license application

Investigational New Drug

Biopharmaceutical

Approved drug

Fast track

Click the tags to see associated articles and topics

FDA Issues Draft Guidance on Its New Platform Technology Designation Program. View article details on hiswai:

Excerpt

Section 506K was established by Section 2503 of the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act of 2022 and ...

Article found on: www.jdsupra.com

View Original Article